Fastened Tight for Better Contrast
Sensitivity of magnetic resonance imaging (MRI) contrast agents raised through multiple bonds to a protein
MRI is based on the intrinsic angular momentum, or spin, of hydrogen atom nuclei. In order to make individual organs visible, the contrast agent must mark them specifically. For example, the contrast agent Vasovist (MS-325) targets blood vessels, making them visible for the study of vascular diseases. Vasovist is a gadolinium complex with a kind of molecular anchor that binds specifically to albumin, a protein present in blood serum. When bound to this large protein, rotation of the gadolinium complex around its own axis is dramatically slowed and yields a stronger signal. A fast rotating contrast agent is less effective in "shaking up" the proton spins, so binding to the target protein improves the effectiveness of the contrast agent, essentially "switching" it on.
Peter Caravan and a team of researchers at EPIX Pharmaceuticals and New York Medical College wanted to increase the sensitivity of MRI for potentially broader applications. Would it be possible to improve the contrast agent by increasing the number of gadolinium complexes? The scientists fastened several gadolinium complexes into a chain with an anchor for albumin at the end, as before. The disadvantage to this approach is that the individual gadolinium complexes within the chain become mobile and able to turn again, putting the desired improvement in contrast out of reach. However, the researchers found a clever way around this. They simply bound a second anchor to the other end of the chain so that the chain binds to the albumin in two places. The chain is thus fastened tightly. The severely reduced mobility of the complexes in the chain is indeed reflected in the significantly increased contrast.
Original publication: P. Caravan; "Multilocus Binding Increases the Relaxivity of Protein-Bound MRI Contrast Agents"; Angewandte Chemie International Edition, doi: 10.1002/anie.200502245
Most read news
Organizations
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.